Health Trials

Congenital Melanocytic Nevus

2

Review clinical trials related to Congenital Melanocytic Nevus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SADBE for Congenital Melanocytic Nevi

A study to evaluate the safety and efficacy topical squaric acid dibutylester (SADBE) for the neoadjuvant treatment of congenital melanocytic nevi (CMN).

Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: May 22, 2026
Eligibility criteria

18 years of age or older. [+2]

Immunosuppressive therapy with glucocorticoid or other systemic immunosuppressan... [+7]

Read more
Status: Recruiting

Precision Medicine for L/GCMN and Melanoma 2

The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fundacion Clinic per a la Recerca BiomédicaUpdated: Feb 27, 2025Locations: 3
Eligibility criteria

Be over 18 years old [+1]

Not signing the informed consent form [+1]

Read more